Free Trial

West Pharmaceutical Services (WST) Earnings Date, Estimates & Call Transcripts

West Pharmaceutical Services logo
$210.72 +7.07 (+3.47%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$208.14 -2.58 (-1.22%)
As of 02/21/2025 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services Latest Earnings Summary

Upcoming Q1
Earnings Date
Apr. 24Before Market OpensEstimated
Actual EPS
(Feb. 13)
$1.82 Beat By $0.07
Consensus EPS
(Feb. 13)
$1.75

West Pharmaceutical Services released Q4 2024 earnings on February 13, 2025, reporting an EPS of $1.82, which beat analysts' consensus estimates of $1.75 by $0.07. Quarterly revenue was reported to be $748.80 million, above analyst estimates of $739.59 million. With a trailing EPS of $6.69 and a P/E Ratio of 31.50, West Pharmaceutical Services' earnings are expected to grow 18.73% next year, from $6.62 to $7.86 per share.

WST Upcoming Earnings

West Pharmaceutical Services' next earnings date is estimated for Thursday, April 24, 2025, based off prior year's reporting schedules.

Get West Pharmaceutical Services Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

WST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

West Pharmaceutical Services Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$1.61$1.63$1.62 
Q2 20252$1.73$1.79$1.76 
Q3 20252$1.84$2.11$1.98 
Q4 20252$2.12$2.25$2.19 
FY 20258$7.30$7.78$7.54 
Q1 20261$1.89$1.89$1.89 
Q2 20261$2.17$2.17$2.17 
Q3 20261$2.11$2.11$2.11 

West Pharmaceutical Services Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/24/2025
(Estimated)
-------
2/13/2025Q4 2024$1.75$1.82+$0.07$1.78$739.59M$748.80M
10/24/2024Q3 2024$1.50$1.85+$0.35$1.85$709.62M$746.90M
7/25/2024Q2 2024$1.74$1.52 -$0.22$1.53$729.36M$702.10M
4/25/2024Q1 2024$1.29$1.56+$0.27$1.57$670.62M$695.40M
2/15/2024Q4 2023$1.78$1.83+$0.05$1.83$740.43M$732.00M
10/26/2023Q3 2023$1.86$2.16+$0.30$2.18$750.31M$747.40M
7/27/2023Q2 2023$1.95$2.11+$0.16$2.16$755.71M$753.80M
4/27/2023Q1 2023$1.67$1.98+$0.31$2.11$697.28M$716.60M

West Pharmaceutical Services Earnings - Frequently Asked Questions

West Pharmaceutical Services has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on WST's earnings history.

West Pharmaceutical Services updated its FY 2025 earnings guidance on Thursday, February, 13th. The company provided earnings per share (EPS) guidance of 6.000-6.200 for the period, compared to the consensus EPS estimate of 7.430. The company issued revenue guidance of $2.9 billion-$2.9 billion, compared to the consensus revenue estimate of $3.0 billion.

In the previous quarter, West Pharmaceutical Services (NYSE:WST) reported $1.82 earnings per share (EPS) to beat the analysts' consensus estimate of $1.75 by $0.07. Learn more on analysts' earnings estimate vs. WST's actual earnings.

The conference call for West Pharmaceutical Services's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for West Pharmaceutical Services's latest earnings report can be read online.
Read Transcript

West Pharmaceutical Services (NYSE:WST) has a recorded annual revenue of $2.89 billion.

West Pharmaceutical Services (NYSE:WST) has a recorded net income of $492.70 million. WST has generated $6.69 earnings per share over the last four quarters.

West Pharmaceutical Services (NYSE:WST) has a trailing price-to-earnings ratio of 31.50 and a forward price-to-earnings ratio of 31.83. The price/earnings-to-growth ratio is 6.74.

West Pharmaceutical Services's earnings are expected to grow from $6.62 per share to $7.86 per share in the next year, which is a 18.73% increase.

More Earnings Resources from MarketBeat



This page (NYSE:WST) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners